Amphastar Pharmaceuticals, Inc. (AMPH) Documents: SEC Filings, Investor Presentations & Press Releases
Amphastar Pharmaceuticals, Inc. (AMPH) documents, SEC filings and the IR site together: 205 documents, newest first; latest 2026-08-06. Read in-app with summaries. First-party data.
Documents — U.S. SEC EDGAR and the company's IR site| Date | Type | Document |
|---|
| 2026-08-06 | Deck | Presentations |
| 2026-08-06 | 8-K | Form 8-K, Item 2.02 results |
| 2026-08-06 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-06 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-13 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-08 | 8-K | Form 8-K, Item 8.01 |
| 2026-06-03 | Deck | Presentations |
| 2026-06-03 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-13 | Deck | Presentations |
| 2026-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2026-05-07 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-14 | Deck | Presentations |
| 2026-04-13 | Proxy | Definitive proxy statement |
| 2026-03-16 | 8-K | Form 8-K, Item 8.01 |
| 2026-03-11 | Deck | Presentations |
| 2026-03-06 | 8-K | Form 8-K, Item 1.01 |
| 2026-03-06 | 8-K | Form 8-K, Item 5.02 |
| 2026-03-01 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-26 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-26 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-01-12 | 8-K | Form 8-K, Item 1.01 |
| 2025-12-03 | Deck | Piper Sandler 37th Annual Healthcare Conference |
| 2025-11-06 | 8-K | Form 8-K, Item 2.02 results |
| 2025-11-06 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-24 | 8-K | Form 8-K, Item 1.01 |
| 2025-09-18 | 8-K | Form 8-K, Item 1.01 |
| 2025-08-12 | 8-K | Form 8-K, Item 1.01 |
| 2025-08-07 | Deck | Presentations |
| 2025-08-07 | 8-K | Form 8-K, Item 2.02 results |
| 2025-08-07 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2025-07-21 | 8-K | Form 8-K, Item 5.02 |
| 2025-06-05 | Deck | Presentations |
| 2025-06-04 | 8-K | Form 8-K, Item 5.03 |
| 2025-05-14 | Deck | Presentations |
| 2025-05-08 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2025-05-07 | Deck | Presentations |
| 2025-05-07 | 8-K | Form 8-K, Item 2.02 results |
| 2025-04-14 | Proxy | Definitive proxy statement |
| 2025-04-09 | Deck | Presentations |
| 2025-03-10 | Deck | Presentations |
AMPH overview · AMPH earnings · AMPH financials · AMPH KPIs · AMPH ownership · AMPH peers
Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.